SGMR Pharmaceuticals Pvt Ltd specializes in the exclusive manufacturing of APIs and intermediates. We leverage novel processes, proven competencies, and state of art facilities for the production of API Products.
We are having around 25 highly professional and experienced scientists in our R & D centre which is located in Aleap Ind Est. NearPragathi Nagar, Hyderabad.
SGMR Pharmaceuticals Pvt Ltd has its presence in more than 80 countries. With established presence in South East Asia, Asia Pacific, Africa, North America, EU & EEA, MENA, Latin America and CIS countries
Good knowledge on cGMP requirements, regulatory requirements, DMF preparations and filing, systems development and implementation
| Products | Intermediates
| # | Category | Product | CAS No. | Status |
|---|---|---|---|---|
| 1 | Atazanavir | (AZS-3)3S,8S,9S,12S)-3,12-Bis(1,1-dimethyl ethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetra decanedioic acid dimethyl ester | 1292296-09-3 | Commercial |
| 2 | Azilsartan | Methyl 1-[(2’-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1h-benzimidazole-7-carboxylate | 139481-44-0 | Under Development |
| Methyl 2-ethoxybenzimidazole-7-carboxylate,methyl 2-ethoxybenzimidazole-7-carboxylate | 150058-27-8 | |||
| 3 | Biperiden Base | Alpha-5-Norbornene-2-yl-alphaphentl-1-piperidinepropanol | 514-65-8 | Commercial |
| 4 | Cyclo propyl Amine (CPA) | 765-30-0 | Commercial | |
| 5 | Dabigartan | {[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]amino}acetic acid | 872728-82-0 | Commercial |
| Ethyl 3-[{[3-methyl-4-(methylamino)phenyl]carbonyl}(pyridin-2-yl)amino]propanoate | 212332-56-0 | Commercial | ||
| 6 | Dapoxetine Base | 119356-77-3 | Commercial | |
| 7 | Darunavir | 2,5-Dioxopyrrolidin-l-yl(3R,3aS,6aR)-hexahydro[2,3-b]furan-3-yl carbonate | 253265-97-3 | Commercial |
| 8 | DCC (1,3 –Di cyclo hexyl carbodiimide | 538-75-0 | Commercial | |
| 9 | Dibenzo-18-crown-6 | 14187-32-7 | Commercial | |
| 10 | Ezetimibe | (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-benzyloxyphenyl)azetidin-2-one | 163222-32-0 | Commercial |
| 11 | Imatinib Base | 4-4[(4-methyl-1-piperazininyl)methyl]-N[4-methyl-3-[[4-{3-pyridinyl)-2-pyrimidinyl]ammo]phenyl}benzamide | 152459-95-5 | Commercial |
| 12 | Imidazole-5-carboxylic ethyl ester | 144689-93-0 | Commercial | |
| 13 | Infigratinib | 5-Amino-3 (trifluoromethyl) pyridine-2-carbonitrile | 573762-62-6 | Commercial |
| 1-(6-Chloropyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methyl urea | --- | Commercial | ||
| 14 | Linezolid | 165800-03-3 | Commercial | |
| 15 | Linalidomide | 3 Amino-piperidine-2,6-dione hydrochloride | 24666-56-6 | Under Development |
| 2-Bromomethyl-3-nitrobenzoic acid methyl ester | 98475-07-1 | |||
| 3-(4-Nitro-1-oxo-1, 3-dihydro-isoindol-2yl)-piperidine-2,6-dione | 827026-45-9 | |||
| 16 | MAP (3-Amino Phenol) | 591-27-5 | Commercial | |
| 17 | N-[4-cyano-3-trifluoromethyl phenyl]-3-[4-fluorophenylthio]-2-hydroxy-2methylpropionamide | 90356-78-8 | Commercial | |
| 18 | N,N-Carbonyl diimidazole (CDI) | 530-62-1 | Commercial | |
| 19 | Palonosetron | (S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalene carboxamide | 135729-78-1 | Under Development |
| 5,6,7,8-Tetrahydronaphthoic acid | 4242-18-6 | |||
| 20 | Piperazine Hydrochloride | 142-64-3 | Commercial | |
| 21 | Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 | Commercial |
| 5-Chlorothiophene-2-carboxylic Acid | 24065-33-6 | |||
| (R)-4-[4-[(3-Chloro-2-hydroxypropyl)amino]phenyl]morpholin-3-one | --- | |||
| 22 | Sodium Azide | 26628-22-8 | Commercial | |
| 23 | Sitagliptin Phosphate Monohydrate | 4-Oxo-4-[3-trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | 119302-20-4 | Commercial |
| (2Z)-4-Oxo-4-[3-trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-en-2-amine | 119302-24-8 | |||
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro [1,2,4]triazolo [4,3-a] pyrazine Hydrochloride | 119302-19-1 | |||
| 24 | Tamsulosin | 5-Acetonyl-2-methoxybenzene sulfonamide | 116091-63-5 | Commercial |
| 5-[(R)-(2-Aminopropyl)]-2-methoxybenzenesulfonamide hydrochloride | 112101-77-6 | |||
| 25 | Trityl Chloride | 76-83-5 | Commercial | |
| 26 | 5-(4’-Bromomethyl-1,1 biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole (TTB) | 124750-51-2 | Commercial | |
| 27 | Thiosalicylic Acid | 147-93-3 | Commercial | |
| 28 | 2-Thiophene Acetyl Chloride | 39098-97-0 | Commercial | |
| 29 | Valacyclovir | N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester | 124832-31-1 | Commercial |
| 30 | Xanthine | 69-89-9 | Commercial | |
| 31 | 4-Pentyne-1-ol | 5390-04-5 | Commercial | |
| 32 | Zonisamide | 1,2-Benzisoxazole-3-acetic acid | 4865-84-3 | Under Development |
| 1,2-Benzisoxazole-3-methanesulfonamide | 68291-97-4 | |||
| 33 | 6-Bromo-3-Hydroxypyrazine-2-Carboxamide | 259793-88-9 | Commercial | |
| 34 | 5-Bromoindole | 10075-50-0 | Commercial | |
| 35 | 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile Dicyclohexylamine Salt | 1137606-74-6 | Commercial | |
| 36 | --- | 6-Bromo-3-Hydroxypyrazine-2-Carboxamide | 259793-88-9 | Commercial |
| 37 | --- | 5-Bromoindole | 10075-50-0 | Commercial |
| 38 | --- | 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile Dicyclohexylamine Salt | 1137606-74-6 | Commercial |
ISO Certified company ISO 9001:2015 & MSME on UDYAM-TS-02-0011766
